Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Idexx Laboratories ( (IDXX) ) has shared an update.
On July 10, 2025, IDEXX Laboratories announced the election of Joseph L. (Jay) Hooley to its Board of Directors as an independent Class III Director, expanding the board from nine to ten members. Hooley, a former Chair and CEO of State Street Corporation, brings extensive strategic and financial leadership experience, which is expected to enhance the board’s effectiveness. His election reflects IDEXX’s commitment to strengthening its governance as it continues to innovate in the pet healthcare industry.
The most recent analyst rating on (IDXX) stock is a Buy with a $575.00 price target. To see the full list of analyst forecasts on Idexx Laboratories stock, see the IDXX Stock Forecast page.
Spark’s Take on IDXX Stock
According to Spark, TipRanks’ AI Analyst, IDXX is a Outperform.
Idexx Laboratories’ strong financial performance and positive technical indicators are the primary drivers of its high score. The company’s robust earnings call further supports a favorable outlook, despite a premium valuation and macroeconomic challenges.
To see Spark’s full report on IDXX stock, click here.
More about Idexx Laboratories
IDEXX Laboratories, Inc. is a global leader in pet healthcare innovation, providing diagnostic and software products and services that enhance veterinary medicine. The company supports the veterinary community worldwide by delivering insights and solutions to improve medical care, efficiency, and practice growth. IDEXX also contributes to the safety of milk and water globally and is a member of the S&P 500 Index, with headquarters in Maine and operations in over 175 countries.
Average Trading Volume: 666,192
Technical Sentiment Signal: Buy
Current Market Cap: $43.33B
For detailed information about IDXX stock, go to TipRanks’ Stock Analysis page.